|
PIGN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14329999911789E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92740000004576E-06 |
| Normal-vs-Stage2 |
1.500690E-03 |
| Normal-vs-Stage3 |
4.14830000350364E-08 |
| Normal-vs-Stage4 |
5.34919999961581E-07 |
| Stage1-vs-Stage2 |
8.588400E-01 |
| Stage1-vs-Stage3 |
1.607880E-02 |
| Stage1-vs-Stage4 |
4.897500E-02 |
| Stage2-vs-Stage3 |
1.713790E-01 |
| Stage2-vs-Stage4 |
2.367200E-01 |
| Stage3-vs-Stage4 |
8.917600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69619999659909E-08 |
| Normal-vs-AfricanAmerican |
3.55920000139065E-08 |
| Normal-vs-Asian |
9.030600E-01 |
| Caucasian-vs-AfricanAmerican |
2.598300E-02 |
| Caucasian-vs-Asian |
2.656000E-01 |
| AfricanAmerican-vs-Asian |
1.565820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.75430003435918E-09 |
| Normal-vs-Female |
3.78710000004112E-06 |
| Male-vs-Female |
2.604400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.535500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.37090000002149E-06 |
| Normal-vs-Age(61-80Yrs) |
3.52339999953877E-07 |
| Normal-vs-Age(81-100Yrs) |
6.337600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.264400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.937000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.028000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.398400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.630000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.563200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.089400E-01 |
| Normal-vs-Grade 2 |
3.92260000000588E-05 |
| Normal-vs-Grade 3 |
1.2237000002191E-07 |
| Normal-vs-Grade 4 |
1.83070000003838E-06 |
| Grade 1-vs-Grade 2 |
3.250800E-01 |
| Grade 1-vs-Grade 3 |
4.464300E-02 |
| Grade 1-vs-Grade 4 |
7.163600E-02 |
| Grade 2-vs-Grade 3 |
1.867880E-02 |
| Grade 2-vs-Grade 4 |
3.080300E-02 |
| Grade 3-vs-Grade 4 |
5.524800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.813200E-04 |
| Normal-vs-ccB subtype |
1.49409999927741E-08 |
| ccA subtype-vs-ccB subtype |
4.234100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49130000015596E-07 |
| Normal-vs-N1 |
1.007190E-01 |
| N0-vs-N1 |
4.761000E-01 |
|
|
